News

Filter

Current filters:

Gemzar

1 to 9 of 164 results

Oncologists backing of combo products supporting cytotoxic market

13-05-2012

The popularity of combination therapies in the treatment of cancer is set to increase, which will help…

BiotechnologyGemzarMarkets & MarketingOncologyPharmaceuticalTaxotere

Hospira gains US approval of solution version of gemcitabine injection

07-08-2011

US generic injectable drug leader Hospira (NYSE: HSP) says the US Food and Drug Administration has approved…

Eli Lillygemcitabine HclGemzarGenericsHospiraNorth AmericaOncologyRegulation

US oncologists see FOLFIRINOX as the most efficacious for advanced pancreatic cancer

07-03-2011

The majority of surveyed US oncologists (57%) identified FOLFIRINOX* as the most efficacious treatment…

Eli LillyFOLFIRINOXGemzarMarkets & MarketingNorth AmericaOncologyPharmaceutical

Pancreatic cancer has high rate of failures in late-stage clinical trials

03-06-2010

The pancreatic cancer market has fewer competitors than most cancer markets, despite being one of the…

Eli LillyGemzarMarkets & MarketingOncologyPharmaceuticalResearch

1 to 9 of 164 results

COMPANY SPOTLIGHT

Menarini

Back to top